Evidence map›Paper›PMID 33270213›Full record

ArticleThe British journal of dermatology2021

Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.

R Laskar, A Ferreiro-Iglesias, D T Bishop, M M Iles, P A Kanetsky, B K Armstrong, M H Law, A M Goldstein, J F Aitken, G G Giles and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The British journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The effects of exposure to solar radiation on human health.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

R LaskarInternational Agency for Research on Cancer, Lyon, France.
A Ferreiro-IglesiasInternational Agency for Research on Cancer, Lyon, France.
D T BishopLeeds Institute of Haematology and Immunology, University of Leeds, Leeds, UK.
M M IlesDivision of Haematology and Immunology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
P A KanetskyCancer Epidemiology Program, Moffitt Cancer Center, Tampa, FL, USA.
B K ArmstrongCancer Epidemiology and Prevention Research Group, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
M H LawStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.ORCID 0000-0002-4303-8821
A M GoldsteinHuman Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
J F AitkenViertel Centre for Research in Cancer Control, the Cancer Council Queensland, Brisbane, QLD, Australia.
G G GilesCancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, Australia.
Australian Melanoma Family Study Investigators
Leeds Case-Control Study Investigators
H A RobbinsInternational Agency for Research on Cancer, Lyon, France.
A E CustInternational Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-5331-6370
Centre international de recherche sur le cancer · FRThe University of Sydney · AUUniversity of Leeds · GBCancer Council Queensland · AUMoffitt Cancer Center · USNational Cancer Institute · USQueensland University of Technology · AUThe University of Melbourne · AU

Funding

Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
Cancer Research UK 11963Cancer Research UK 19167Cancer Research UK C588/A10589Cancer Research UK C588/A19167Cancer Research UK C588/A4994Cancer Research UK C8216/A6129NCI NIH HHS R01 CA083115NIH HHSWorld Health Organization 001
6 · The paper itself

Abstract

backgroundMelanoma aetiology has been proposed to have two pathways, which are determined by naevi and type of sun exposure and related to the anatomical site where melanoma develops.

objectivesWe examined associations with melanoma by anatomical site for a comprehensive set of risk factors including pigmentary and naevus phenotypes, ultraviolet radiation exposure and polygenic risk.

methodsWe analysed harmonized data from 2617 people with incident first invasive melanoma and 975 healthy controls recruited through two population-based case-control studies in Australia and the UK. Questionnaire data were collected by interview using a single protocol, and pathway-specific polygenic risk scores were derived from DNA samples. We estimated adjusted odds ratios using unconditional logistic regression that compared melanoma cases at each anatomical site with all controls.

resultsWhen cases were compared with control participants, there were stronger associations for many naevi vs. no naevi for melanomas on the trunk, and upper and lower limbs than on the head and neck (P-heterogeneity < 0·001). Very fair skin (vs. olive/brown skin) was more weakly related to melanoma on the trunk than to melanomas at other sites (P-heterogeneity = 0·04). There was no significant difference by anatomical site for polygenic risk. Increased weekday sun exposure was positively associated with melanoma on the head and neck but not on other sites.

conclusionsWe found evidence of aetiological heterogeneity for melanoma, supporting the dual pathway hypothesis. These findings enhance understanding of risk factors for melanoma and can guide prevention and skin examination education and practices.

Indexed as

MelanomaSkin NeoplasmsAustraliaHumansRisk FactorsUltraviolet Rays

Identifiers

PMID33270213
PMCPMC9969114
OpenAlexW3110379785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.